1      0

2021 AGA Postgraduate Course


25.3 - Immune Disease of the Liver: AIH, PBC, PSC


May 1, 2021 1:10pm ‐ May 1, 2021 2:00pm

Learning Objectives:
  • Upon completion of this activity, participants will be able to decide on the best treatment approach for patients with AIH who fail to respond to standard of care
  • Upon completion of this activity, participants will be able to identify patients with PBC who are likely to progress despite receiving first line therapy with ursodeoxycholic acid
  • Upon completion of this activity, participants will be able to apply a valid surveillance strategy for hepatobiliary malignancies in patients with PSC

Speaker(s):

You must be logged in and own this session in order to post comments.